Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581763 · ClinicalTrials.gov registry record
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 110
- Enrollment target
NCT00581763 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 110 participants.
The verdict
NCT00581763 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This is a study about why some people have certain types of proteins in their blood, called anti-phospholipid antibodies. The presence of these antibodies and associated complications (e.g. blood clots) are known to change over time. The purpose of this study is to evaluate these changes and improve our ability to determine the long-term outcome of affected individuals.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2001-05 |
| Est. Completion | 2019-12-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581763
The ClinicalTrials.gov registry entry for NCT00581763 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00581763 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581763 about?
NCT00581763 is a clinical study titled "Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies". This is a study about why some people have certain types of proteins in their blood, called anti-phospholipid antibodies. The presence of these antibodies and associated complications (e.g. blood clots) are known to change over time. The purpose of this study is to evaluate these changes and improve...
What is the current status of trial NCT00581763?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2001-05. Estimated completion is 2019-12-20.
Who is sponsoring clinical trial NCT00581763?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.